IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:909-916.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-1188

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, T.
Right arrow Articles by Kinoshita, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, T.
Right arrow Articles by Kinoshita, S.

The Use of Autologous Serum in the Development of Corneal and Oral Epithelial Equivalents in Patients with Stevens-Johnson Syndrome

Takahiro Nakamura,1,2 Leonard P. K. Ang,1,3 Helen Rigby,4 Eiichi Sekiyama,1 Tsutomu Inatomi,1 Chie Sotozono,1 Nigel J. Fullwood,4 and Shigeru Kinoshita1

1From the Department of Ophthalmology, Kyoto Prefectural University of Medicine, Graduate School of Medicine, Kyoto, Japan; 2Research Center for Regenerative Medicine, Doshisha University, Kyoto, Japan; 3Singapore National Eye Center, Singapore; and 4Institute of Environmental and Natural Sciences, Lancaster University, Lancaster, United Kingdom.

PURPOSE. To evaluate the use of autologous serum (AS) from patients with severe ocular surface disease (OSD) in the development of transplantable corneal and oral epithelial tissue equivalents and to compare it with the use of conventional culture methods by using fetal bovine serum (FBS).

METHODS. AS was obtained from patients with severe OSD secondary to Stevens-Johnson syndrome. Corneal and oral epithelial cells were cultivated in medium supplemented with either AS or FBS. Corneal and oral epithelial equivalents were constructed on denuded amniotic membranes. The bromodeoxyuridine (BrdU) ELISA cell proliferation assay and colony-forming efficiency (CFE) of cells cultivated in AS- or FBS-supplemented media were compared. The morphologic characteristics and the basement membrane assembly of cultivated epithelial equivalents were analyzed by light and electron microscopy, as well as by immunohistochemistry.

RESULTS. BrdU proliferation assay and CFE analysis showed that human corneal and oral epithelial cells cultivated in AS-supplemented media had comparable proliferative capacities compared with FBS-supplemented media. The corneal and oral epithelial equivalents cultivated in AS- and FBS-supplemented media were morphologically similar and demonstrated the normal expression of tissue-specific keratins and basement membrane assembly. The presence of a well-formed stratified epithelium, a basement membrane, and hemidesmosomal attachments was confirmed by electron microscopy.

CONCLUSIONS. AS-supplemented cultures were effective in supporting the proliferation of human corneal and oral epithelial cells, as well as the development of transplantable epithelial equivalents. The use of AS is of clinical importance in the development of autologous xenobiotic-free bioengineered ocular surface equivalents for clinical transplantation.





This article has been cited by other articles:


Home page
IOVSHome page
S. Yokoo, S. Yamagami, T. Usui, S. Amano, and M. Araie
Human Corneal Epithelial Equivalents for Ocular Surface Reconstruction in a Complete Serum-Free Culture System without Unknown Factors
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2438 - 2443.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Raeder, T. P. Utheim, O. A. Utheim, B. Nicolaissen, B. Roald, Y. Cai, K. Haug, A. Kvalheim, E. B. Messelt, L. Drolsum, et al.
Effects of Organ Culture and Optisol-GS Storage on Structural Integrity, Phenotypes, and Apoptosis in Cultured Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5484 - 5493.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
N. Di Girolamo, J. Chui, D. Wakefield, and M. T Coroneo
Cultured human ocular surface epithelium on therapeutic contact lenses
Br. J. Ophthalmol., April 1, 2007; 91(4): 459 - 464.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Nakamura, K.-i. Endo, and S. Kinoshita
Identification of Human Oral Keratinocyte Stem/Progenitor Cells by Neurotrophin Receptor p75 and the Role of Neurotrophin/p75 Signaling
Stem Cells, March 1, 2007; 25(3): 628 - 638.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
L. P. K. Ang, T. Nakamura, T. Inatomi, C. Sotozono, N. Koizumi, N. Yokoi, and S. Kinoshita
Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease.
Arch Ophthalmol, November 1, 2006; 124(11): 1543 - 1551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology